Literature DB >> 21296820

In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography.

Andrea Giani1, Aristomenis Thanos, Mi In Roh, Edward Connolly, George Trichonas, Ivana Kim, Evangelos Gragoudas, Demetrios Vavvas, Joan W Miller.   

Abstract

PURPOSE: To describe the in vivo evolution of laser-induced choroidal neovascularization (CNV) in mice using spectral domain optical coherence tomography (SD-OCT).
METHODS: Laser photocoagulation was applied to the mouse fundus using a 532-nm diode laser (100, 150, and 200 mW; 100-μm diameter, 0.1-second duration). SD-OCT examination was performed immediately after laser application and at days 3, 5, 7, 14, 21, and 28 after laser. Fluorescein angiography (FA) was performed at day 5, 7, 14, and 28. Acquired SD-OCT images were analyzed to describe morphologic features, measure CNV size and retinal thickness, and assess the frequency of lesions resulting in fluid accumulation. Finally, SD-OCT images were compared to fluorescein angiograms and histologic sections with immunostaining at similar time points.
RESULTS: SD-OCT allowed visualization of the initial laser damage and the subsequent stages of the injury response. CNV formation reached its maximum size at day 5. By day 7, significant size reduction was observed (P < 0.001), continuing through days 14 and 28. Exudation signs, such as fluid accumulation and increase in retinal thickness, followed the same time course, with a peak at day 5 and a decrease by day 7. Delivery of higher laser energy levels to the RPE/choroid complex resulted in a significant percentage of lesions demonstrating excessive chorioretinal damage without CNV formation.
CONCLUSIONS: SD-OCT is a fast and reliable tool for the in vivo evaluation of laser-induced CNV, allowing quantification of lesion size and exudation parameters. Moreover, it provides morphologic information that correlates with histologic findings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296820     DOI: 10.1167/iovs.10-6266

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  54 in total

1.  In-vivo and ex-vivo characterization of laser-induced choroidal neovascularization variability in mice.

Authors:  Robert Hoerster; Philipp S Muether; Sarah Vierkotten; Susanne Schröder; Bernd Kirchhof; Sascha Fauser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-16       Impact factor: 3.117

Review 2.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

3.  A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization.

Authors:  Rania S Sulaiman; Judith Quigley; Xiaoping Qi; Michael N O'Hare; Maria B Grant; Michael E Boulton; Timothy W Corson
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-10       Impact factor: 2.671

4.  Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse.

Authors:  Aristomenis Thanos; Yuki Morizane; Yusuke Murakami; Andrea Giani; Dimosthenis Mantopoulos; Maki Kayama; Mi In Roh; Norman Michaud; Basil Pawlyk; Michael Sandberg; Lucy H Young; Joan W Miller; Demetrios G Vavvas
Journal:  Am J Pathol       Date:  2012-03-17       Impact factor: 4.307

5.  Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.

Authors:  Nathaniel Parsons; Balasubramaniam Annamalai; Elisabeth Obert; Gloriane Schnabolk; Stephen Tomlinson; Bärbel Rohrer
Journal:  Mol Immunol       Date:  2019-02-12       Impact factor: 4.407

6.  Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases.

Authors:  Pedro Cuevas; Luis Outeiriño; Carlos Azanza; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-09-03

7.  Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.

Authors:  Eiichi Hasegawa; Saori Inafuku; Lama Mulki; Yoko Okunuki; Ryoji Yanai; Kaylee E Smith; Clifford B Kim; Garrett Klokman; Diane R Bielenberg; Narender Puli; John R Falck; Deeba Husain; Joan W Miller; Matthew L Edin; Darryl C Zeldin; Kin Sing Stephen Lee; Bruce D Hammock; Wolf-Hagen Schunck; Kip M Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

8.  Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology.

Authors:  Elisabeth Obert; Randy Strauss; Carlene Brandon; Christina Grek; Gautam Ghatnekar; Robert Gourdie; Bärbel Rohrer
Journal:  J Mol Med (Berl)       Date:  2017-01-28       Impact factor: 4.599

9.  Ocular cytomegalovirus latency exacerbates the development of choroidal neovascularization.

Authors:  Jinxian Xu; Xinglou Liu; Xinyan Zhang; Brendan Marshall; Zheng Dong; Yutao Liu; Diego G Espinosa-Heidmann; Ming Zhang
Journal:  J Pathol       Date:  2020-05-21       Impact factor: 7.996

10.  A Mouse Model for Laser-induced Choroidal Neovascularization.

Authors:  Ronil S Shah; Brian T Soetikno; Michelle Lajko; Amani A Fawzi
Journal:  J Vis Exp       Date:  2015-12-27       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.